The results suggest that EGCG is a tumor suppressor by increasing the apoptotic level in human thyroid carcinoma cells via EGFR/RAS/RAF/MEK/ERK signaling pathway. This evidence concerns the gene MAP2K7 and thyroid gland carcinoma.